NIH has an historic opportunity to transform post-viral illness research by bringing ME/CFS into its long Covid RECOVER ...

Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms – including reduced physical exercise capacity and reduced cognitive test performances – for a year or more, with ...

This is the first post in a series about the lingering effects of COVID. The age-honored trope of the transition from an old year to a brand-new one is the handoff from a husk of an aging ...

The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.

According to the results, 4.5% post-COVID-19 participants met ME/CFS diagnostic criteria, compared to 0.6% participants that had not been infected by SARS-CoV-2 virus. RECOVER is NIH's national ...